Dr. Morath, a Shareholder, holds a Ph.D. in Molecular Biology from the University of Utah, a B.S. in Cellular and Molecular Biology from the University of Michigan, and a J.D. from Brigham Young University.

Dr. Morath's doctoral dissertation was centered around the development of glial stem cells, and specifically on the metal requirements for proper fate specification and differentiation. As a post-doctoral fellow, Dr. Morath staged the embryonic lethality of Anitizyme 1/2 knockout mice, generated novel myoblast cell lines and explored the effects of gentamicin treatment on stop codon readthrough.

Technical Expertise
• Biotechnology

Prior Professional Experience
• Research fellow, Gesteland lab, University of Utah

Education
• University of Michigan, B.S. in Cellular and Molecular Biology
• University of Utah, Ph.D. in Molecular Biology
• Brigham Young University, Juris Doctor

Bar Admissions
• U.S. Patent & Trademark Office
• Utah Bar

Morath and Mayer-Pröschel. "Iron modulates the differentiation of a distinct population of glial precursor cells into oligodendrocytes." Developmental Biology 237(1) (2001): 232-43.

Mayer-Pröschel, Morath, and Noble. "Are hypothyroidism and iron deficiency precursor cell diseases?" Developmental Neuroscience 23(4-5) (2001):277-86.

Morath and Mayer-Pröschel. "Iron Deficiency during embryogenesis and consequences for oligodendrocyte generation in vivo." Developmental Neuroscience 24(2-3) (2002):197-207.